Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study
Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortal...
Saved in:
| Published in | PLoS medicine Vol. 19; no. 10; p. e1004109 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
18.10.2022
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1549-1676 1549-1277 1549-1676 |
| DOI | 10.1371/journal.pmed.1004109 |
Cover
| Abstract | Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years.
Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings.
In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. |
|---|---|
| AbstractList | Using data from the Whitehall II cohort study, Severine Sabia and colleagues investigate whether sleep duration is associated with subsequent risk of developing multimorbidity among adults age 50, 60, and 70 years old in England. Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Methods and findings Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. Conclusions In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Methods and findings Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping [less than or equal to]5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) [greater than or equal to]9 hours. Compared to 7-hour sleep, sleep duration [less than or equal to]5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration [greater than or equal to]9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping [less than or equal to]5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration [greater than or equal to]9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. Conclusions In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Methods and findings Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. Conclusions In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Methods and findings Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. Conclusions In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. Using data from the Whitehall II cohort study, Severine Sabia and colleagues investigate whether sleep duration is associated with subsequent risk of developing multimorbidity among adults age 50, 60, and 70 years old in England. Author summary Why was this study done? The prevalence of multimorbidity is on the rise as reflected in over half of older adults having at least 2 chronic diseases in high-income countries, making multimorbidity a major challenge for public health. Both short and long sleep duration has been shown to be associated with individual chronic diseases, but their associations with multimorbidity and subsequent mortality risk remain unclear. What did the researchers do and find? We used data on more than 7,000 men and women from the Whitehall II cohort study to extract sleep duration at age 50, 60, and 70 and examined its association with incident multimorbidity over 25 years of follow-up. Role of sleep duration at age 50 in transitions from a healthy state to a first chronic disease, multimorbidity, and mortality was also examined using a multistate model. We found a robust association of sleep duration ≤5 hours at age 50, 60, and 70 (separate analyses) with higher risk of incident multimorbidity, while the association with sleep duration ≥9 hours was observed only when measured at age 60 and 70. Analysis of transitions in health states showed short sleep duration at age 50 to be associated with 20% increased risk of a first chronic disease, and with a similar increased risk of subsequent multimorbidity, but within this framework there was no clear evidence of associations with mortality. There was no robust association between sleep duration ≥9 hours at age 50 and risk of 1 chronic disease or multimorbidity. However, in those with a chronic condition there was some evidence of higher risk of multimorbidity. What do these findings mean? Our comprehensive analyses of the association of sleep duration with multimorbidity and the natural course of chronic disease show short sleep duration to be associated with the onset of chronic disease and multimorbidity but not with subsequent mortality in those with chronic disease(s). There was no clear evidence for an association between long sleep duration at age 50 and risk of chronic disease. Rather the increased risk of multimorbidity associated with long sleep duration at older ages and in those with existing disease might reflect the need for longer sleep in those with underlying chronic conditions. Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years.BACKGROUNDSleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years.Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings.METHODS AND FINDINGSData were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings.In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity.CONCLUSIONSIn this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity. |
| Audience | Academic |
| Author | Singh-Manoux, Archana Dugravot, Aline Kivimaki, Mika Sabia, Séverine Léger, Damien Ben Hassen, Céline |
| AuthorAffiliation | 2 Department of Epidemiology and Public Health, University College London, London, United Kingdom 5 Clinicum, University of Helsinki, Helsinki, Finland 3 Université Paris Cité, EA 7330 VIFASOM (Vigilance Fatigue Sommeil et Santé Publique), Paris, France 4 APHP, Hôtel-Dieu, Consultation de pathologie professionnelle Sommeil Vigilance et Travail, Centre du Sommeil et de la Vigilance, Paris, France 1 Université Paris Cité, Inserm U1153, Epidemiology of Ageing and Neurodegenerative diseases, Paris, France Harvard Medical School, UNITED STATES |
| AuthorAffiliation_xml | – name: 4 APHP, Hôtel-Dieu, Consultation de pathologie professionnelle Sommeil Vigilance et Travail, Centre du Sommeil et de la Vigilance, Paris, France – name: 3 Université Paris Cité, EA 7330 VIFASOM (Vigilance Fatigue Sommeil et Santé Publique), Paris, France – name: 1 Université Paris Cité, Inserm U1153, Epidemiology of Ageing and Neurodegenerative diseases, Paris, France – name: 5 Clinicum, University of Helsinki, Helsinki, Finland – name: 2 Department of Epidemiology and Public Health, University College London, London, United Kingdom – name: Harvard Medical School, UNITED STATES |
| Author_xml | – sequence: 1 givenname: Séverine orcidid: 0000-0003-3109-9720 surname: Sabia fullname: Sabia, Séverine – sequence: 2 givenname: Aline orcidid: 0000-0002-4546-0970 surname: Dugravot fullname: Dugravot, Aline – sequence: 3 givenname: Damien orcidid: 0000-0003-1168-480X surname: Léger fullname: Léger, Damien – sequence: 4 givenname: Céline orcidid: 0000-0001-7884-2986 surname: Ben Hassen fullname: Ben Hassen, Céline – sequence: 5 givenname: Mika orcidid: 0000-0002-4699-5627 surname: Kivimaki fullname: Kivimaki, Mika – sequence: 6 givenname: Archana orcidid: 0000-0002-1244-5037 surname: Singh-Manoux fullname: Singh-Manoux, Archana |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36256607$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVk2uL1DAUhousuBf9B6IBQRTsmKRt2uwHYVi8DC4uqKsfQyY9nWbNNGOSus7v8A-b7szIzDKIUkrDyXMuydv3ODnobAdJ8pDgEclK8vLK9q6TZrSYQz0iGOcE8zvJESlynhJWsoOt9WFy7P0VxpRjju8lhxmjBWO4PEp-jb23SsugbYdsg7wBWKC6d6uIDEjOABX4BWLxlV2NSoyWIJ1H1zq0yGn_bcib9ybouXVTXeuwRLpDoQV0-f4U0SIdeNRYY-x12i8GfNj82uoArTQGTSZI2da6gHzo6-X95G4jjYcH6-9Jcvnm9eezd-n5xdvJ2fg8VSXLQ1pkNeEYZ00lG64ITIkiPMukKmg2LWilcsVxDkzSmmW4ATzlPMtZRaqcMuA4O0ker-oujPVifZ9e0DJeb1ZUJY_EZEXUVl6JhdNz6ZbCSi1uAtbNhHRBKwOCxX6MVAwD5bkijaSyzBsKRckYjW1jrVfrbv00SqagC06anaK7O51uxcz-ELwoq4IPwzxbF3D2ew8-iLn2CoyRHdh-mDuKWkSRaUSf3EL3n25NzWQ8gO4aG_uqoagYlzQvi6piWaTSPdQMOohDxl-y0TG8w4_28PGpYa7V3oTnOwmRCfAzzGTvvZh8-vgf7Id_Zy--7LJPt9gWpAmtt6YfTOB3wUfbKv6Rb-OoCJyuAOWs9w4aoXS4MVO8Bm0EwWKw70YQMdhXrO0bk_NbyZv6f037DdR-RHA |
| CitedBy_id | crossref_primary_10_1016_j_lanepe_2024_100922 crossref_primary_10_1016_j_bbih_2024_100754 crossref_primary_10_1016_j_sleep_2023_12_023 crossref_primary_10_1016_S1474_4422_22_00481_1 crossref_primary_10_1111_eci_14002 crossref_primary_10_1080_10911359_2024_2407914 crossref_primary_10_1038_s41598_025_85163_3 crossref_primary_10_1186_s12889_024_20524_7 crossref_primary_10_1007_s11606_023_08429_4 crossref_primary_10_1016_j_sleh_2023_12_002 crossref_primary_10_1111_ggi_14897 crossref_primary_10_1136_bmjph_2024_000952 crossref_primary_10_1016_j_sleep_2023_07_002 crossref_primary_10_1186_s12889_023_15894_3 crossref_primary_10_1007_s11357_025_01593_x crossref_primary_10_1093_sleep_zsad130 crossref_primary_10_1186_s12889_024_17762_0 crossref_primary_10_1038_s44220_025_00395_6 crossref_primary_10_1016_j_puhe_2023_10_004 crossref_primary_10_3390_nu17050796 crossref_primary_10_1155_2024_2304723 crossref_primary_10_1016_j_sleep_2024_02_043 crossref_primary_10_1016_j_envint_2023_108348 crossref_primary_10_1016_j_jad_2024_08_200 crossref_primary_10_1016_j_advnut_2024_100275 crossref_primary_10_1212_CON_0000000000001323 crossref_primary_10_1016_j_sleep_2024_10_022 crossref_primary_10_1016_j_sleep_2024_09_029 crossref_primary_10_1080_21548331_2024_2320069 crossref_primary_10_1016_j_gerinurse_2023_10_005 crossref_primary_10_3390_ijerph20085509 crossref_primary_10_1007_s44337_024_00060_4 crossref_primary_10_1098_rspb_2023_2115 crossref_primary_10_1002_alz_13562 crossref_primary_10_1038_s41420_024_02214_w crossref_primary_10_1016_j_smrv_2024_101968 crossref_primary_10_12677_ijpn_2024_131001 crossref_primary_10_2147_NSS_S473022 crossref_primary_10_1371_journal_pcbi_1011849 crossref_primary_10_1161_JAHA_123_029463 crossref_primary_10_1016_j_psyneuen_2024_107065 crossref_primary_10_1016_S0140_6736_24_01296_0 crossref_primary_10_36150_2499_6564_N274 crossref_primary_10_1016_j_jadohealth_2023_08_010 crossref_primary_10_1177_07334648241242687 crossref_primary_10_1038_s41598_024_54254_y crossref_primary_10_7189_jogh_14_04034 crossref_primary_10_2147_JMDH_S419306 crossref_primary_10_1016_j_jad_2024_03_051 |
| Cites_doi | 10.1097/EDE.0000000000000184 10.1093/ageing/afx201 10.1016/j.sleep.2021.03.015 10.1186/s12966-021-01150-7 10.1093/sleep/33.5.585 10.1016/S0140-6736(12)60240-2 10.1016/0140-6736(91)93068-K 10.1136/bmjopen-2020-043276 10.1016/j.sleep.2013.04.001 10.1097/EDE.0000000000000688 10.1016/j.smrv.2017.06.011 10.1016/j.sleep.2020.07.002 10.1016/j.sleh.2016.01.006 10.1371/journal.pone.0195002 10.1001/jama.2012.5265 10.1038/s41467-021-22354-2 10.1016/j.sleep.2016.08.006 10.1177/0049124113503141 10.1016/0895-4356(88)90138-2 10.1371/journal.pmed.1002503 10.1016/j.sleep.2017.01.016 10.1136/bmj-2021-068005 10.1093/ageing/afw044 10.1093/sleep/zsy252 10.1016/j.jalz.2018.02.012 10.5935/1984-0063.20180036 10.1146/annurev.clinpsy.121208.131413 10.1186/s12916-020-01846-w 10.1016/j.sleh.2014.12.010 10.1161/CIRCULATIONAHA.115.017719 10.1136/bmjopen-2018-026942 10.1016/S2468-2667(21)00107-9 10.1093/aje/kwt330 10.1016/j.jsmc.2017.09.001 10.1037/hea0000739 10.1016/j.sleep.2013.02.002 10.1371/journal.pone.0142533 10.1053/smrv.2001.0246 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2022 Public Library of Science 2022 Sabia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Sabia et al 2022 Sabia et al |
| Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Sabia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Sabia et al 2022 Sabia et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA CZK |
| DOI | 10.1371/journal.pmed.1004109 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals PLoS Medicine |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Sleep and multimorbidity |
| EISSN | 1549-1676 |
| ExternalDocumentID | 2737135879 oai_doaj_org_article_68c461860e294c1fa2a74f2e57662346 PMC9578599 A724758863 36256607 10_1371_journal_pmed_1004109 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | London United Kingdom United Kingdom--UK |
| GeographicLocations_xml | – name: London – name: United Kingdom – name: United Kingdom--UK |
| GrantInformation_xml | – fundername: Medical Research Council grantid: S011676 – fundername: Medical Research Council grantid: MR/R024227/1 – fundername: NIA NIH HHS grantid: RF1 AG062553 – fundername: Wellcome Trust grantid: 221854/Z/20/Z – fundername: NIA NIH HHS grantid: R01 AG056477 – fundername: Medical Research Council grantid: K013351 – fundername: British Heart Foundation grantid: RG/16/11/32334 – fundername: Medical Research Council grantid: MR/S011676/1 – fundername: Medical Research Council grantid: R024227 – fundername: ; grantid: RG/16/11/32334 – fundername: ; grantid: 221854/Z/20/Z – fundername: ; grantid: R01AG056477, RF1AG062553 – fundername: ; grantid: ANR-19-CE36-0004-01 – fundername: ; grantid: R024227, S011676, K013351 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ADRAZ ADXHL CGR CUY CVF ECM EIF H13 IPNFZ NPM PJZUB PPXIY RIG WOQ PMFND 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM AAPBV ABPTK BCGST CZK ICW M~E UMP |
| ID | FETCH-LOGICAL-c764t-53d19003f8af9c1eb1c1933ac523b528c4c904e6a2d630fe0b99346818426e903 |
| IEDL.DBID | M48 |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Sun May 07 16:26:43 EDT 2023 Wed Aug 27 01:30:04 EDT 2025 Thu Aug 21 18:39:51 EDT 2025 Fri Sep 05 06:00:27 EDT 2025 Sat Jul 26 00:20:01 EDT 2025 Tue Jun 17 21:11:34 EDT 2025 Thu Jun 12 23:57:13 EDT 2025 Tue Jun 10 20:39:42 EDT 2025 Fri Jun 27 04:38:43 EDT 2025 Fri Jun 27 04:18:32 EDT 2025 Fri Jun 27 04:53:46 EDT 2025 Thu May 22 21:21:51 EDT 2025 Mon Jul 21 06:08:03 EDT 2025 Tue Jul 01 04:28:37 EDT 2025 Thu Apr 24 22:52:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c764t-53d19003f8af9c1eb1c1933ac523b528c4c904e6a2d630fe0b99346818426e903 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors have declared that no competing interests exist. |
| ORCID | 0000-0002-4699-5627 0000-0003-3109-9720 0000-0001-7884-2986 0000-0002-4546-0970 0000-0003-1168-480X 0000-0002-1244-5037 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pmed.1004109 |
| PMID | 36256607 |
| PQID | 2737135879 |
| PQPubID | 1436338 |
| ParticipantIDs | plos_journals_2737135879 doaj_primary_oai_doaj_org_article_68c461860e294c1fa2a74f2e57662346 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9578599 proquest_miscellaneous_2725650022 proquest_journals_2737135879 gale_infotracmisc_A724758863 gale_infotracgeneralonefile_A724758863 gale_infotracacademiconefile_A724758863 gale_incontextgauss_ISR_A724758863 gale_incontextgauss_ISN_A724758863 gale_incontextgauss_IOV_A724758863 gale_healthsolutions_A724758863 pubmed_primary_36256607 crossref_citationtrail_10_1371_journal_pmed_1004109 crossref_primary_10_1371_journal_pmed_1004109 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20221018 |
| PublicationDateYYYYMMDD | 2022-10-18 |
| PublicationDate_xml | – month: 10 year: 2022 text: 20221018 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | IS Ho (pmed.1004109.ref030) 2021; 6 The Academy of Medical Sciences (pmed.1004109.ref006) 2018 PC Austin (pmed.1004109.ref037) 2016; 133 S Sabia (pmed.1004109.ref022) 2021; 12 S Sindi (pmed.1004109.ref031) 2020; 18 DL Vetrano (pmed.1004109.ref032) 2018; 15 L He (pmed.1004109.ref009) 2021; 18 MZ Hossin (pmed.1004109.ref015) 2016; 2 O Itani (pmed.1004109.ref016) 2017 J McNeil (pmed.1004109.ref001) 2019; 42 ME Tinetti (pmed.1004109.ref007) 2012; 307 K Nicholson (pmed.1004109.ref011) 2020; 75 S Sabia (pmed.1004109.ref025) 2014; 179 GD Batty (pmed.1004109.ref040) 2014; 25 A Kingston (pmed.1004109.ref042) 2018; 47 M Hirshkowitz (pmed.1004109.ref014) 2015; 1 BL Jones (pmed.1004109.ref023) 2013; 42 FP Cappuccio (pmed.1004109.ref017) 2013; 14 K Nicholson (pmed.1004109.ref029) 2019; 38 K Barnett (pmed.1004109.ref008) 2012; 380 DS Nagin (pmed.1004109.ref024) 2010; 6 CD Jenkins (pmed.1004109.ref027) 1988; 41 EJ Stepanski (pmed.1004109.ref044) 2003; 7 C Reis (pmed.1004109.ref013) 2018; 11 A Sommerlad (pmed.1004109.ref035) 2018; 14 J Yin (pmed.1004109.ref003) 2017; 6 M Kivimäki (pmed.1004109.ref034) 2017; 28 M Jike (pmed.1004109.ref019) 2018 M Ruiz-Castell (pmed.1004109.ref010) 2019; 9 J Li (pmed.1004109.ref020) 2018; 13 J Juhola (pmed.1004109.ref028) 2021; 11 P. Lambert (pmed.1004109.ref039) 2010 AK Helbig (pmed.1004109.ref012) 2017; 33 MG Marmot (pmed.1004109.ref021) 1991; 337 pmed.1004109.ref041 VT van Hees (pmed.1004109.ref026) 2015; 10 C Ben Hassen (pmed.1004109.ref033) 2022; 376 R Palladino (pmed.1004109.ref043) 2016; 45 FP Cappuccio (pmed.1004109.ref004) 2010; 33 World Health Organisation. (pmed.1004109.ref005) 2016 F Tao (pmed.1004109.ref002) 2021; 81 Springer (pmed.1004109.ref038) 2001 CA Magee (pmed.1004109.ref018) 2013; 14 KAS Davis (pmed.1004109.ref036) 2018; 13 |
| References_xml | – volume: 25 start-page: 932 issue: 6 year: 2014 ident: pmed.1004109.ref040 article-title: Generalizability of occupational cohort study findings. publication-title: Epidemiology (Cambridge, Mass). doi: 10.1097/EDE.0000000000000184 – volume: 6 issue: 9 year: 2017 ident: pmed.1004109.ref003 article-title: Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. publication-title: J Am Heart Assoc – volume: 47 start-page: 374 issue: 3 year: 2018 ident: pmed.1004109.ref042 article-title: Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model publication-title: Age Ageing doi: 10.1093/ageing/afx201 – volume: 81 start-page: 401 year: 2021 ident: pmed.1004109.ref002 article-title: Associations of sleep duration and quality with incident cardiovascular disease, cancer, and mortality: a prospective cohort study of 407,500 UK biobank participants publication-title: Sleep Med doi: 10.1016/j.sleep.2021.03.015 – volume: 18 start-page: 77 issue: 1 year: 2021 ident: pmed.1004109.ref009 article-title: The prevalence of multimorbidity and its association with physical activity and sleep duration in middle aged and elderly adults: a longitudinal analysis from China publication-title: Int J Behav Nutr Phys Act doi: 10.1186/s12966-021-01150-7 – start-page: S457176 year: 2010 ident: pmed.1004109.ref039 article-title: PARTPRED: Stata module to generate partial predictions publication-title: Stat Softw Components. – volume: 33 start-page: 585 issue: 5 year: 2010 ident: pmed.1004109.ref004 article-title: Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies publication-title: Sleep doi: 10.1093/sleep/33.5.585 – volume: 380 start-page: 37 issue: 9836 year: 2012 ident: pmed.1004109.ref008 article-title: Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study publication-title: Lancet doi: 10.1016/S0140-6736(12)60240-2 – volume: 337 start-page: 1387 issue: 8754 year: 1991 ident: pmed.1004109.ref021 article-title: Health inequalities among British civil servants: the Whitehall II study publication-title: Lancet doi: 10.1016/0140-6736(91)93068-K – volume: 11 start-page: e043276 issue: 1 year: 2021 ident: pmed.1004109.ref028 article-title: Internal consistency and factor structure of Jenkins Sleep Scale: cross-sectional cohort study among 80 000 adults publication-title: BMJ Open. doi: 10.1136/bmjopen-2020-043276 – volume: 14 start-page: 587 issue: 7 year: 2013 ident: pmed.1004109.ref017 article-title: Sleep and mortality: cause, consequence, or symptom? publication-title: Sleep Med doi: 10.1016/j.sleep.2013.04.001 – volume: 28 start-page: 735 issue: 5 year: 2017 ident: pmed.1004109.ref034 article-title: Validity of Cardiovascular Disease Event Ascertainment Using Linkage to UK Hospital Records. publication-title: Epidemiology (Cambridge, Mass). doi: 10.1097/EDE.0000000000000688 – start-page: 25 issue: 39 year: 2018 ident: pmed.1004109.ref019 article-title: Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression publication-title: Sleep Med Rev doi: 10.1016/j.smrv.2017.06.011 – year: 2001 ident: pmed.1004109.ref038 – volume: 75 start-page: 156 year: 2020 ident: pmed.1004109.ref011 article-title: Sleep behaviours and multimorbidity occurrence in middle-aged and older adults: findings from the Canadian Longitudinal Study on Aging (CLSA). publication-title: Sleep Med doi: 10.1016/j.sleep.2020.07.002 – volume: 2 start-page: 146 issue: 2 year: 2016 ident: pmed.1004109.ref015 article-title: From habitual sleep hours to morbidity and mortality: existing evidence, potential mechanisms, and future agenda publication-title: Sleep Health doi: 10.1016/j.sleh.2016.01.006 – volume: 13 start-page: e0195002 issue: 3 year: 2018 ident: pmed.1004109.ref036 article-title: Using data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics (HES). publication-title: PLoS ONE doi: 10.1371/journal.pone.0195002 – volume: 307 start-page: 2493 issue: 23 year: 2012 ident: pmed.1004109.ref007 article-title: Designing health care for the most common chronic condition—multimorbidity publication-title: JAMA doi: 10.1001/jama.2012.5265 – year: 2018 ident: pmed.1004109.ref006 article-title: Multimorbidity: a priority for global health research – volume: 12 start-page: 2289 issue: 1 year: 2021 ident: pmed.1004109.ref022 article-title: Association of sleep duration in middle and old age with incidence of dementia. publication-title: Nat Commun doi: 10.1038/s41467-021-22354-2 – year: 2016 ident: pmed.1004109.ref005 article-title: Multimorbidity: Technical Series on Safer publication-title: Primary Care – start-page: 246 issue: 32 year: 2017 ident: pmed.1004109.ref016 article-title: Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression publication-title: Sleep Med doi: 10.1016/j.sleep.2016.08.006 – volume: 42 start-page: 608 issue: 4 year: 2013 ident: pmed.1004109.ref023 article-title: A Note on a Stata Plugin for Estimating Group-based Trajectory Models publication-title: Sociol Methods Res doi: 10.1177/0049124113503141 – volume: 41 start-page: 313 issue: 4 year: 1988 ident: pmed.1004109.ref027 article-title: A scale for the estimation of sleep problems in clinical research publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(88)90138-2 – volume: 15 start-page: e1002503 issue: 3 year: 2018 ident: pmed.1004109.ref032 article-title: Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: A Swedish cohort study. publication-title: PLoS Med doi: 10.1371/journal.pmed.1002503 – volume: 33 start-page: 151 year: 2017 ident: pmed.1004109.ref012 article-title: Relationship between sleep disturbances and multimorbidity among community-dwelling men and women aged 65–93 years: results from the KORA Age Study publication-title: Sleep Med doi: 10.1016/j.sleep.2017.01.016 – volume: 376 start-page: e068005 year: 2022 ident: pmed.1004109.ref033 article-title: Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study publication-title: BMJ doi: 10.1136/bmj-2021-068005 – volume: 45 start-page: 431 issue: 3 year: 2016 ident: pmed.1004109.ref043 article-title: Associations between multimorbidity, healthcare utilisation and health status: evidence from 16 European countries publication-title: Age Ageing doi: 10.1093/ageing/afw044 – volume: 42 issue: 3 year: 2019 ident: pmed.1004109.ref001 article-title: Sleep and cancer incidence in Alberta’s Tomorrow Project cohort publication-title: Sleep doi: 10.1093/sleep/zsy252 – volume: 14 start-page: 933 issue: 7 year: 2018 ident: pmed.1004109.ref035 article-title: Accuracy of general hospital dementia diagnoses in England: Sensitivity, specificity, and predictors of diagnostic accuracy 2008–2016 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2018.02.012 – volume: 11 start-page: 217 issue: 4 year: 2018 ident: pmed.1004109.ref013 article-title: Sleep duration, lifestyles and chronic diseases: a cross-sectional population-based study. publication-title: Sleep Sci. doi: 10.5935/1984-0063.20180036 – volume: 6 start-page: 109 year: 2010 ident: pmed.1004109.ref024 article-title: Group-based trajectory modeling in clinical research publication-title: Annu Rev Clin Psychol doi: 10.1146/annurev.clinpsy.121208.131413 – volume: 18 start-page: 382 issue: 1 year: 2020 ident: pmed.1004109.ref031 article-title: Sleep disturbances and the speed of multimorbidity development in old age: results from a longitudinal population-based study publication-title: BMC Med doi: 10.1186/s12916-020-01846-w – volume: 1 start-page: 40 issue: 1 year: 2015 ident: pmed.1004109.ref014 article-title: National Sleep Foundation’s sleep time duration recommendations: methodology and results summary publication-title: Sleep Health doi: 10.1016/j.sleh.2014.12.010 – volume: 133 start-page: 601 issue: 6 year: 2016 ident: pmed.1004109.ref037 article-title: Introduction to the Analysis of Survival Data in the Presence of Competing Risks publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.017719 – volume: 9 start-page: e026942 issue: 8 year: 2019 ident: pmed.1004109.ref010 article-title: Sleep duration and multimorbidity in Luxembourg: results from the European Health Examination Survey in Luxembourg, 2013–2015 publication-title: BMJ Open doi: 10.1136/bmjopen-2018-026942 – volume: 6 start-page: e587 issue: 8 year: 2021 ident: pmed.1004109.ref030 article-title: Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies publication-title: Lancet Public Health doi: 10.1016/S2468-2667(21)00107-9 – volume: 179 start-page: 781 issue: 6 year: 2014 ident: pmed.1004109.ref025 article-title: Association between questionnaire- and accelerometer-assessed physical activity: the role of sociodemographic factors publication-title: Am J Epidemiol doi: 10.1093/aje/kwt330 – volume: 13 start-page: 1 issue: 1 year: 2018 ident: pmed.1004109.ref020 article-title: Sleep in Normal Aging publication-title: Sleep Med Clin doi: 10.1016/j.jsmc.2017.09.001 – ident: pmed.1004109.ref041 – volume: 38 start-page: 783 issue: 9 year: 2019 ident: pmed.1004109.ref029 article-title: The measurement of multimorbidity. publication-title: Health Psychol doi: 10.1037/hea0000739 – volume: 14 start-page: 591 issue: 7 year: 2013 ident: pmed.1004109.ref018 article-title: Investigation of the relationship between sleep duration, all-cause mortality, and preexisting disease publication-title: Sleep Med doi: 10.1016/j.sleep.2013.02.002 – volume: 10 start-page: e0142533 issue: 11 year: 2015 ident: pmed.1004109.ref026 article-title: A Novel, Open Access Method to Assess Sleep Duration Using a Wrist-Worn Accelerometer. publication-title: PLoS ONE doi: 10.1371/journal.pone.0142533 – volume: 7 start-page: 215 issue: 3 year: 2003 ident: pmed.1004109.ref044 article-title: Use of sleep hygiene in the treatment of insomnia publication-title: Sleep Med Rev doi: 10.1053/smrv.2001.0246 |
| SSID | ssj0029090 |
| Score | 2.606212 |
| Snippet | Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly... Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults,... Using data from the Whitehall II cohort study, Severine Sabia and colleagues investigate whether sleep duration is associated with subsequent risk of... Background Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults,... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1004109 |
| SubjectTerms | Age Aged Arthritis Biology and Life Sciences Cancer Cardiovascular disease Chronic diseases Chronic illnesses Cohort analysis Cohort Studies Comorbidity Data collection Dementia Diabetes Electronic health records Ethnicity Evaluation Female Follow-Up Studies Health aspects Health services Humans Kidney cancer Liver cancer London - epidemiology Male Medicine and Health Sciences Middle Aged Mortality Multimorbidity Prospective Studies Questionnaires Risk Factors Sleep Sleep Wake Disorders - epidemiology Sociodemographics |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELVQD4gL4nsDBQxCcCGsk9hxzG1BrLagXSSgaG-R49hLpZJUTSrE7-APM-OkUYMq7R449BK_ROrM2H6TjN8Q8gIFPoQrk9DKBBIUoVmoUbZSGcmFcKwQvnvD6Vl6Mucfz8X5TqsvrAnr5IE7wx2mmeGo6c5srLiJnI615C62wJNh5-ZebJsptk2m-lRLMf92BfXHwiiWsj80l8josPfRmxXsNlgjwH0x4s6m5LX7hxV6slrWzT76-W8V5c62dHyL3Oz5JD3q_sdtcs1Wd8j10_6L-V3yZ8f-tHa0WVq7ouWmczzVLYUFhQr2mqbw01VJJaO_Ifwbiq9oKZae432-8PBnvS4WJfB2uqgoMEc6__SWxiJEPHUQUfWvcLNCOA763nvYq4XOZhQb8a5b6tVs75H58Ydv70_CvhFDaGTK21AkZYRvPF2mnTIRLO8GeF-iDWSxhYjBQ0YxblMdl2nCnGUFsB6eAheA_d8qltwnk6qu7AGhzJZcRaXGxrucaVHE1mQaOJyD50TGBSTZeiI3vUo5NstY5v7Tm4RspTNsjv7Le_8FJBzuWnUqHZfg36GTByxqbPsLEHl5H3n5ZZEXkKcYInl3YHVYKfIjGXPIwrI0Cchzj0CdjQoLeS70pmny2efvVwB9PbsK6MsI9KoHuRpsZnR_wgIsjyJfI-TLEfKikzjfB5yOgLD2mNHwAU6PrY2bHMgw9nzMJJh4up0y-4efDcP4UCz1q2y9QQywcIHcMiAPuhk2-AnYFqQfTAZEjubeyJHjkWrxw4umK1R1Uurh__D8I3IjxlMwWNiUTcmkXW_sY-CmbfHEL0N_AeiJhbc priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nj9MwELWgSIgL4nsDCxiE4EJ2ncSOEy5oQay2oF0koKi3yHGcUqkkoWmF-B38YWYcN9ugCvbQS_0StZ7M-I0zfkPIMxT4EGUR-UZGkKAIxXyFspWpllyIkuXCdm84PYtPJvz9VEzdhlvryio3MdEG6qLWuEd-CMssdpNLZPq6-eFj1yh8u-paaFwmVwJgIti6QU7PE66U2T0WVCHzg1BKd3QObnToLHXQwJqDlQLcliRuLU1Wwb-P06NmUbe7SOjftZRbi9PxDXLdsUp61D0GN8klU90iV0_de_Pb5PeWFWhd0nZhTEOLdWd-qlYUwgoV7CWN4aOqgkpGf4ETtBQ3aikWoON1tvzwe73M5wWwdzqvKPBHOvnwiobCRzwt4bmqf_rrBuE4aDvwYccWOh5TbMe7XFGraXuHTI7ffXl74rt2DL6WMV_5IioC3PcsE1WmOoAgr2HOI6Uhl81FmGiuU8ZNrMIijlhpWA7ch8fACIAFmJRFd8moqiuzRygzBU-DQmH7Xc6UyEOjEwVMroT7BLr0SLSxRKadVjm2zFhk9gWchJylm9gM7Zc5-3nE769qOq2O_-DfoJF7LCpt2y_q5SxzjpvF8L-wpwAzYcp1UKpQSV6GBvI0YI489shjfESy7thqHy-yIxlyyMWSOPLIU4tAtY0Ky3lmat222fjj1wuAPp9dBPRpAHrhQGUNc6aVO2cBM49SXwPk8wFy1gmd7wLuD4AQgfRgeA_dYzPHbXbuq3DlxmV2Dz_ph_GmWPBXmXqNGODiAhmmR-51HtbbCTgXJCFMekQOfG9gyOFINf9mpdNT1HZK0_v__lkPyLUQT7lg4VKyT0ar5do8BO65yh_ZAPMHWeN-mw priority: 102 providerName: ProQuest |
| Title | Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36256607 https://www.proquest.com/docview/2737135879 https://www.proquest.com/docview/2725650022 https://pubmed.ncbi.nlm.nih.gov/PMC9578599 https://doaj.org/article/68c461860e294c1fa2a74f2e57662346 http://dx.doi.org/10.1371/journal.pmed.1004109 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZGJyFeEL8XKMUgBC9kchInTpAQ2tCmlWkFBkV9ixzHLpVKUppWsL-Df5g7J40WVMQe2of6s6Xe-ezv7PMdIc8xwUdo8sDVIgAHJZTMlZi2MlGCh6FhWWirN5yNopMxfz8JJztkU7O1EWC11bXDelLj5Xz_14-Lt2Dwb2zVBuFtOu0vYP_AW3_u4Yu-XXtjhMF8vL1X8BNmT10wL5nr-UI0j-n-NUpns7I5_duVu7eYl9U2Wvp3dOWl7er4FrnZ8Ex6UE-M22RHF3fI9bPmJv0u-X1JL7Q0tJprvaD5up4QVK4oLDQ0ZK9oBB9Z5FQwegFmUVE8uqUYko79bEDi93KZzXLg83RWUGCUdHz6mvqhi3hqYKaVP931AuHYaGvyYQ0XOhxSLNC7XFGb5fYeGR8ffXl34jYFGlwlIr5ywyD38CTUxNIkyoNlXwEfDKQC7zYL_VhxlTCuI-nnUcCMZhmwIR4BRwBeoBMW3Ce9oiz0HqFM5zzxcokFeTmTYeZrFUvgdgbG8ZRxSLDRRKqa7OVYRGOe2is5AV5MLdgU9Zc2-nOI2_Za1Nk7_oM_RCW3WMy9bX8ol9O0MeU0gv-FVQaY9hOuPCN9KbjxNXhuwCV55JAnOEXS-iFru4KkB8Ln4J3FUeCQZxaB-TcKDPCZynVVpcMPX68A-jy6Cui8A3rZgEwJMlOyeXkBksfkXx3kiw5yWqc-3wbsd4CwJqlO8x6ax0bGVQokGWtBxgJE3N-YzPbmp20zDoohgIUu14gBdh4i53TIg9rCWj0BCwO3hAmHiI7tdRTZbSlm32wy9QSzPSXJw6sI8hG54ePrFwxoivukt1qu9WPgpKtsQK6JiRiQ3cOj0cfzgT3Zge_TT_HALkB_AN67isQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkYAXxH2FwQzi8kKYmzhxgoTQuEwtXYvEVtS34Dh2qVSS0rSa9jv4H_xGznHSrkEV7GUPfak_R4mPfS728fkIeYoFPnyTeo4WHgQovmSOxLKVkRLc9w1LfMve0OsH7QH_NPSHW-T38i4MplUudaJV1GmucI98D8wsssmFIno7_ekgaxSeri4pNMpp0dWnJxCyFW86H0C-z1z34OPx-7ZTsQo4SgR87vhe2sLtOxNKE6kW6CoFTownFYRkie-GiquIcR1INw08ZjRLwITzAAwbGDMdMQ-ee4lc5njECOtHDM8CvIjZPR2seua0XCGqq3rw4nvVzHg1BRuHmQncpkCumULLGLCyC43pJC82Ob1_526uGcODG-R65cXS_XLa3SRbOrtFrvSqc_rb5Nea1GluaDHRekrTRTndqJxTUGPUZy9pAD-ZpVQwegqjW1DcGKaY8I79bLrjj3yWjFOIFug4o-Cv0kH3NXV9B_HUwDzOT5zFFOHYaBn_kCGGdjoU6X9nc2pr6N4hgwsR1F3SyPJMbxPKdMqjViqR7pcz6SeuVqEEz9HAc1rKNIm3lESsqtroSNExie2Bn4AYqRzYGOUXV_JrEmfVa1rWBvkP_h0KeYXFyt72j3w2iitFEQfwXchhwLQbcdUy0pWCG1dDXAieKg-aZBenSFxek13pp3hfuBxivzDwmuSJRWB1jwzTh0ZyURRx5_PXc4CO-ucBfamBXlQgk8OYKVnd64CRx9JiNeTzGnJUFlbfBNypAUHjqVrzNi6P5RgX8ZlugJ7LJbO5-fGqGR-KCYaZzheIAd_fR4-2Se6VK2wlJ_DxIOhhoklEbe3VBFlvycbfban2CGtJRdH9f7_WLrnaPu4dxoedfvcBuebiDRtMmgp3SGM-W-iH4PfOk0dW2VDy7aK12x-_I7nC |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJ028IO4LDGYQlxdC3cSJG6QJbWzTyliZBkV7C65jl0ojKU2rab-Df8Wv4hzHDQuaYC976Ev8OWp87HOxj79DyDMk-IhMFvpahBCgRJL5EmkrEyV4FBk2jGz1hoN-vDfg74-j4yXya3EXBtMqFzrRKuqsULhH3gYzi9XkuiJpG5cWcbi9-3byw8cKUnjSuiinIV2ZhWzD0o25Sx77-uwUwrlyo7cNsn8eBLs7n9_t-a7igK9EzGd-FGYd3NozXWkS1QE9psDBCaWCcG0YBV3FVcK4jmWQxSEzmg3BvPMYjB4YOp2wEN57jSwLsPoQCC5v7fQPj-rwL2F2xwc50fxOIIS7yAef1Xbz5vUELCDmLXCbIHnOUNp6ArXVaE1OivIil_jvzM5zpnL3JrnhfFy6WU3KW2RJ57fJyoE7xb9Dfp6bE7QwtDzRekKzeTUZqZxRUHI0Yq9oDD-ZZ1QwegbjW1LcNqaYDo_9bDLk92I6HGcQS9BxTsGbpYP9NzSIfMRTA7O8OPXnE4Rjo60HiPVjaK9HsTjwdEYtw-5dMrgSUd0jrbzI9SqhTGc86WQSiwFzJqNhoFVXgl9p4D0dZTwSLiSRKsecjgU8TlJ7HCgggqoGNkX5pU5-HvHrXpOKOeQ_-C0Uco1F3m_7oJiOUqdG0hi-CyscMB0kXHWMDKTgJtAQNYIfy2OPrOMUSatLtLX2SjdFwCEy7MahR55aBHJ_5LiKRnJelmnv45dLgD71LwM6aoBeOpApYMyUdLc-YOSReKyBfNFAjira9YuAaw0g6EPVaF7F5bEY4zL9ozmg52LJXNz8pG7Gl2L6Ya6LOWIgMojQ3_XI_WqF1XICDxBCIiY8IhprryHIZks-_maJ3BNkmkqSB__-W-tkBTRd-qHX339Irgd4_QYzqrprpDWbzvUjcIpnw8dO21Dy9aoV3G_xhcSd |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+sleep+duration+at+age+50%2C+60%2C+and+70+years+with+risk+of+multimorbidity+in+the+UK%3A+25-year+follow-up+of+the+Whitehall+II+cohort+study&rft.jtitle=PLoS+medicine&rft.au=Sabia%2C+S%C3%A9verine&rft.au=Dugravot%2C+Aline&rft.au=L%C3%A9ger%2C+Damien&rft.au=Ben+Hassen%2C+C%C3%A9line&rft.date=2022-10-18&rft.pub=Public+Library+of+Science&rft.issn=1549-1277&rft.volume=19&rft.issue=10&rft_id=info:doi/10.1371%2Fjournal.pmed.1004109&rft.externalDBID=ISR&rft.externalDocID=A724758863 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |